Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How often should lurbinectedin's long term effects be monitored?How does lipitor's effectiveness differ for arthritis pain?How many years does kadcyla's market exclusivity last?When will latisse patent expire?How does renal function impact tigecycline's liver safety?
See the DrugPatentWatch profile for simponi
Yes. Simponi (golimumab) is approved for psoriatic arthritis and can be used to treat adults with active psoriatic arthritis [1].
Simponi is used to reduce signs and symptoms of psoriatic arthritis and is typically prescribed when the condition is active [1].
Simponi is given by injection. Whether a patient can use Simponi for psoriatic arthritis depends on the prescribed dosing regimen and the patient’s overall treatment plan [1].
Use of Simponi for psoriatic arthritis requires standard biologic safety considerations (such as infection risk and screening requirements) because it suppresses parts of the immune system. The exact steps and suitability are determined by the treating clinician based on the patient’s history and risk factors [1].
[1] DrugPatentWatch.com (Simponi/golimumab information and indications): https://www.drugpatentwatch.com/p/golimumab-simponi
Other Questions About Simponi :